查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529636

网路 POC 血糖测试市场规模、份额、趋势分析报告：按产品、按地区、细分市场预测，2024-2030 年

Network Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格
简介目录

网路 POC 血糖测试市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球网路POC血糖检测市场规模将达17.9亿美元，2024年至2030年复合年增长率为4.4%。

对安全、准确的远端患者监护选项的需求不断增长以及对资料驱动的治疗方法的需求是推动市场的关键因素。低功耗蓝牙 (BLE) 和红外线等先进技术的整合预计将在未来几年推动市场成长。

亚太地区和中东地区不断增长的患者群体和对先进糖尿病管理系统的高需求正在为这些地区创造巨大的成长机会。这些地区也包括备受青睐的医疗旅游目的地地区。对世界一流医疗保健服务的需求不断增长以及先进技术的不断采用是推动这些地区市场成长的一些因素。

网路 POC 血糖仪广泛应用于 COVID-19 护理。这使得医生能够远端监测血糖浓度，同时将感染风险降至最低。此外，目前正在使用大量资料为糖尿病 COVID-19 患者量身定制治疗计划。对远端医疗的偏好以及慢性病患者家庭医疗保健环境的趋势是预计扩大基于网路的 POC 设备使用的一些因素。

网路 POC 血糖检测市场报告亮点

  • 在 COVID-19 的第一波和第二波疫情期间，联网 POC 设备因其在远端患者监护方面的优势而需求量很大。
  • 按产品划分，Accu-Chek Inform II 细分市场占据主导地位，2023 年收益占有率为 48.4%，预计在预测期内将以有利的成长率扩张。
  • 北美在 2023 年以 40.7% 的收益占有率占据市场主导地位，由于主要参与者的存在和高渗透率等因素，预计在预测期内将保持领先地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 网路 POC 血糖测试市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 网路POC血糖测试市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 网路POC血糖检测市场：依产品估算及趋势分析

  • 细分仪表板
  • 网路 POC 血糖测试市场：2023 年和 2030 年按产品分類的变化分析
  • i-STAT
  • Accu 检查通知 II
  • 统计条
  • 血液提示
  • CareSense 专家增强版
  • Barozen H 专家增强版

第五章网路POC血糖检测市场：区域估算及趋势分析

  • 2023年及2030年网路POC血糖检测市场占有率（按地区）
  • 北美洲
    • 北美网路 POC 血糖检测市场估计与预测，2018-2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲网路POC血糖检测市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太网路 POC 血糖检测市场估计与预测，2018-2030 年
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 拉丁美洲网路 POC 血糖测试市场估计与预测，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 中东和非洲网路 POC 血糖检测市场估计和预测，2018-2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Abbott, LLC
    • Nova Biomedical
    • Danaher
    • F. Hoffmann-La Roche Ltd.
    • Ascensia Diabetes Care Holdings AG.
    • Prodigy Diabetes Care, LLC
    • Nipro Corporation Japan
    • ACON Laboratories, Inc.
简介目录
Product Code: GVR-4-68039-609-7

Network Point-of-Care Glucose Testing Market Growth & Trends:

The global network point-of-care glucose testing market size is expected to reach USD 1.79 billion by 2030, registering a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.

Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.

Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.

Network Point-of-Care Glucose Testing Market Report Highlights:

  • Network point-of-care devices were in high demand during the first and second wave of COVID-19 owing to their advantage of remote patient monitoring
  • Based on product, the Accu-Chek Inform II segment dominated the market and accounted for a revenue share of 48.4% in 2023 and is expected to expand at a lucrative growth rate during the forecast period
  • North America dominated the market with a revenue share of 40.7% in 2023 and is predicted to maintain its lead over the forecast period owing to the factors such as the presence of major players and high adoption rate

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Network Point-of-Care Glucose Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Network Point-of-Care Glucose Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Network Point-of-Care Glucose Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Network Point-of-Care Glucose Testing Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. i-STAT
    • 4.3.1. i-STAT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Accu-Chek Inform II
    • 4.4.1. Accu-Chek Inform II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. StatStrip
    • 4.5.1. StatStrip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. HemoCue
    • 4.6.1. HemoCue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. CareSens Expert Plus
    • 4.7.1. CareSens Expert Plus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. BAROzen H Expert Plus
    • 4.8.1. BAROzen H Expert Plus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Network Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Network Point-of-Care Glucose Testing Market Share, By Region, 2023 & 2030 (USD Million)
  • 5.2. North America
    • 5.2.1. North America Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. UK Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. France Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Norway Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. China Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. India Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Abbott, LLC
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/Strategic Initiatives
    • 6.4.2. Nova Biomedical
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/Strategic Initiatives
    • 6.4.3. Danaher
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/Strategic Initiatives
    • 6.4.4. F. Hoffmann-La Roche Ltd.
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/Strategic Initiatives
    • 6.4.5. Ascensia Diabetes Care Holdings AG.
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/Strategic Initiatives
    • 6.4.6. Prodigy Diabetes Care, LLC
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/Strategic Initiatives
    • 6.4.7. Nipro Corporation Japan
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/Strategic Initiatives
    • 6.4.8. ACON Laboratories, Inc.
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/Strategic Initiatives